Cambridge Epigenetix

Google’s GV leads $21M Series B in bioscience firm Cambridge Epigenetix

Mar 17, 2016 Natasha Lomas

VC firm GV (née Google Ventures) has made another investment in Europe -- its seventh -- leading a $21 million Series B round for epigenetic sequencing tech company and Cambridge University spin-out,